RIFAXIMIN IMPROVES BOTH ABDOMINAL PAIN AND BLOATING IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A COMPOSITE ENDPOINT ANALYSIS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

被引：0
|
作者：
Lacy, Brian E.
Chang, Lin
Rao, Satish S.
Heimanson, Zeev
Sayuk, Gregory S.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fr255
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [41] Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
    Spiller, Robin
    Pelerin, Fanny
    Decherf, Amelie Cayzeele
    Maudet, Corinne
    Housez, Beatrice
    Cazaubiel, Murielle
    Justen, Peter
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (03) : 353 - 362
  • [42] AST-120 (Spherical Carbon Adsorbent) Improves Pain and Bloating in a Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Non-Constipating Irritable Bowel Syndrome (IBS)
    Tack, Jan F.
    Harris, M. S.
    Proksch, Scott
    Bornstein, Jeffrey D.
    Miner, Philip B.
    GASTROENTEROLOGY, 2010, 138 (05) : S223 - S223
  • [43] Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials
    Pimentel, Mark
    Cash, Brooks D.
    Wolf, Ray
    Lembo, Anthony J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S254
  • [44] Effect of Eluxadoline on Health-Related Quality of Life in Adults With Irritable Bowel Syndrome With Diarrhea: Results From Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
    Andrae, David
    Buono, Jessica L.
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S494 - S494
  • [45] Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea
    Harris, Lucinda
    Lucak, Susan
    Chang, Lin
    Dove, Leonard S.
    Covington, Paul S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S748 - S748
  • [46] Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety
    Lembo, Anthony
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    McIntyre, Gail
    Almenoff, June
    Covington, Paul S.
    GASTROENTEROLOGY, 2014, 146 (05) : S159 - S159
  • [47] A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
    Giannetti, Eleonora
    Maglione, Marco
    Alessandrella, Annalisa
    Strisciuglio, Caterina
    De Giovanni, Donatella
    Campanozzi, Angelo
    Miele, Erasmo
    Staiano, Annamaria
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2017, 51 (01) : E5 - E10
  • [48] Characterization of abdominal pain response to rifaximin in patients with irritable bowel syndrome with diarrhea (IBS-D), by baseline (BL) pain severity
    Lembo, A.
    Heimanson, Z.
    Cash, B. D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [49] Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study
    Kim, Hee-Young
    Park, Eui-Seong
    Choi, Young Sik
    Park, Seun Ja
    Kim, Jae Hyun
    Chang, Hee Kyung
    Park, Kun-Young
    FOOD & NUTRITION RESEARCH, 2022, 66
  • [50] EFFICACY OF PROBIOTICS FOR IRRITABLE BOWEL SYNDROME: A META-ANALYSIS OF RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    Shi, Lubo
    Zhang, Wenxue
    Wu, Shanshan
    Zhou, Minsi
    Wu, Jing
    Shi, Haiyun
    GUT, 2022, 71 : A159 - A160
12345